Advertisement

Topics

Latest "A Study On Amprenavir In Combination With Other Anti-HIV Drugs In HIV-Positive Patients" News Stories

22:32 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "A Study On Amprenavir In Combination With Other Anti-HIV Drugs In HIV-Positive Patients" found in our extensive news archives from over 250 global news sources.

More Information about A Study On Amprenavir In Combination With Other Anti-HIV Drugs In HIV-Positive Patients on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about A Study On Amprenavir In Combination With Other Anti-HIV Drugs In HIV-Positive Patients for you to read. Along with our medical data and news we also list A Study On Amprenavir In Combination With Other Anti-HIV Drugs In HIV-Positive Patients Clinical Trials, which are updated daily. BioPortfolio also has a large database of A Study On Amprenavir In Combination With Other Anti-HIV Drugs In HIV-Positive Patients Companies for you to search.

Showing "Study Amprenavir Combination With Other Anti Drugs Positive" News Articles 1–25 of 31,000+

Tuesday 18th December 2018

STAT Plus: “It’s a matter of taking what Mother Nature’s developed already, and using it as a template to create new drugs.” https://buff.ly/2SVSqGx 

STAT Plus: “It’s a matter of taking what Mother Nature’s developed already, and using it as a template to create new drugs.” https://buff.ly/2SVSqGx 


Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study

Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts


Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study

Study by @IndianaUniv researchers “raises important questions about the relationship between the primary ingredients in cannabis and their effect on the eye." http://ow.ly/uyVr30n21yL 

Study by @IndianaUniv researchers “raises important questions about the relationship between the primary ingredients in cannabis and their effect on the eye." http://ow.ly/uyVr30n21yL 

Interesting stat in IQVIA new #OrphanDrug report ~40% (217/503) orphan drugs no longer protected by either orphan exclusivity or patent designations, but only half (116) of these currently face generic competitors https://www.iqvia.com/institute/report

Interesting stat in IQVIA new #OrphanDrug report ~40% (217/503) orphan drugs no longer protected by either orphan exclusivity or patent designations, but only half (116) of these currently face generic competitors https://www.iqvia.com/institute/reports/orphan-drugs-in-the-united-states-exclusivity-pricing-and-treated-populations?sf96397592=1&sf96397592=1 …

Rhinovirus Infections Global Clinical Trials Review, H2, 2018 [Report Updated: 31072018] Prices from USD $2125

Rhinovirus Infections Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Rhinovirus Infections Global Clinical Trials Review, H2, 2018" provides an overview of Rhinovirus Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Rhinovirus Infections. Report includes an overview of trial numbers and their average enrol...

MOD Resources (MOD) - Discoveries made, exploration concept validated

Edison Investment Research - Mining - MOD Resources: MOD Resources (MOD) is a copper-silver exploration and development company with a substantial ground holding in the Kalahari Copper Belt, Botswana. The company has been very successful with its regional exploration concept, which has led to the discovery and drill-out of the significant T3 copper-silver deposit and the delineation of a prelimina...

New RNA sequencing strategy to study gut microbiome activity

Researchers have developed a high-throughput RNA sequencing strategy to study the activity of the gut microbiome. The new tools analyse transfer RNA (tRNA), a molecular Rosetta Stone that translates the genetic information encoded in DNA into proteins that perform basic biological functions. Developing a clear picture of tRNA dynamics will allow scientists to understand the activity of naturally ...

Akaal Pharma Pty Ltd Announces Licensing Agreement for its First-in-Class, Topical Spingosine-1-Phosphate-1 (S1P1) Receptor Modulator for Atopic Dermatitis and Psoriasis

Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has entered into a licensing agreement for Akaal Pharma’s First-in-Class, topical Spingosine-1-Phosphate-1 (S1P1) modulator, AKP-11, with Boston Pharmaceuticals, Inc. (Boston Pharmaceuticals). AKP-11 is a differentiated S1P1 modulator, which potentially has clinical applications in a number ...

Tetra Discovery Partners and Shionogi & Co., Ltd. Collaborate on BPN14770 Development and Commercialization

Deal Valued at Potential $160 Million plus Royalties, including $5 Million in Upfront Payments and $35 Million in Equity Investment Shionogi Gains Regional License to Alzheimer’s Drug Candidate for Japan, Korea and Taiwan Collaboration to Accelerate BPN14770 Clinical Development in Fragile X Syndrome and Early...

Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer

Granulomatosis with Polyangiitis Wegener's Granulomatosis Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2125

Granulomatosis with Polyangiitis Wegener's Granulomatosis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Granulomatosis with Polyangiitis Wegener's Granulomatosis Global Clinical Trials Review, H2, 2018" provides an overview of Granulomatosis with Polyangiitis Wegener's Granulomatosis clinical trials scenario. This report provides top line data relating to the cl...

ASCO 2018 - Will Taking Mod to High Dose Steroids Affect Lung Cancer Patients on Immunotherapy?

ASCO 2018 RoundtableHoward (Jack) West, MD, Founder and President

Greenberg Traurig’s Lori Cohen Selected as a 2018 Law360 Life Sciences MVP

Hard-hitting attorney Lori G. Cohen, co-chair of the Global Litigation Practice at Greenberg Traurig, LLP, as well as chair of the firm's Trial Practice Group and its Pharmaceutical, Medical Device & Health Care Litigation Practice, has been selected by Law360 as a 2018 Life Sciences MVP attorney. ATLANTA (PRWEB) December 18, 2018 Hard-hitting attorney Lori G. Cohen, co-chair of the Globa...

ASCO 2018 Roundtable - Checkmate 227 - Combinations of Nivolumab and Ipilimumab, or Nivolumab and and Chemo

ASCO 2018 Roundtable Howard (Jack) West, MD, Founder and President

Ligand Introduces 2019 Financial Outlook and Raises 2018 Financial Guidance

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) introduces its financial outlook for 2019. Ligand expects revenue in 2019 to be at least $212 million, with up to an additional $40 million of potential milestone and license payments. Approximately two thirds of the $212 million of revenue is expected to be royalty revenue, and the remainder is expected t...

South Korea Respiratory Device Accessories Market Outlook to 2025 [Report Updated: 03102018] Prices from USD $4246

South Korea Respiratory Device Accessories Market Outlook to 2025SummaryGlobalData's new report, South Korea Respiratory Device Accessories Market Outlook to 2025, provides key market data on the South Korea Respiratory Device Accessories market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Aerosol Masks, CardioPulmonary Resus...

Teen pot users may hallucinate, become paranoid

(Reuters Health) - - More than two in five teens who use marijuana experience psychotic symptoms like hallucinations, paranoia and anxiety, a U.S. study suggests.

Mexico Respiratory Device Accessories Market Outlook to 2025 [Report Updated: 12102018] Prices from USD $4246

Mexico Respiratory Device Accessories Market Outlook to 2025SummaryGlobalData's new report, Mexico Respiratory Device Accessories Market Outlook to 2025, provides key market data on the Mexico Respiratory Device Accessories market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Aerosol Masks, CardioPulmonary Resuscitation CPR Ba...

Radiomic features classify lung cancer from benign nodules

Radiomic features extracted from CT images accurately distinguished small-cell lung cancer from benign nodules, according to a retrospective study published Dec. 18 in Radiology.

Wiring diagram of brain reconciles inconsistent neuroimaging findings of Alzheimer’s patients 

Using data from the Human Connectome Project, researchers were able to reassess inconsistent findings from neuroimaging studies of Alzheimer’s patients, according to a new study published online Dec. 14 in the journal BRAIN.

Insulet to Present at the 37th Annual J.P. Morgan Healthcare Conference

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 8, 2019, at 11:30 a.m. (Pacific Time). The presentation will be followed b...

Study Shows Taltz Superior to Humira for Patients With Active Psoriatic Arthritis

NewsLilly Announces Positive Top-Line Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis

Must Read: New analysis from @BRGexpert provides further evidence the #340B program’s structure incentivizes hospitals to use more expensive treatments & drives up costs for both taxpayers & Medicare beneficiaries. https://catalyst.phrma.org/new-study-

Must Read: New analysis from @BRGexpert provides further evidence the #340B program’s structure incentivizes hospitals to use more expensive treatments & drives up costs for both taxpayers & Medicare beneficiaries. https://catalyst.phrma.org/new-study-finds-hospitals-prescribe-more-medicines-and-more-expensive-medicines-after-joining-340b-program-to-capitalize-on-significant-disc...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks